| Primary |
| Gastrooesophageal Reflux Disease |
41.2% |
| Cerebrovascular Accident Prophylaxis |
11.8% |
| Ischaemic Heart Disease Prophylaxis |
11.8% |
| Prophylaxis |
11.8% |
| Dyspepsia |
5.9% |
| Gastritis |
5.9% |
| Influenza Like Illness |
5.9% |
| Product Used For Unknown Indication |
5.9% |
|
| Diarrhoea |
12.5% |
| Nephrolithiasis |
12.5% |
| Treatment Noncompliance |
12.5% |
| Drug Interaction |
6.3% |
| Hospitalisation |
6.3% |
| Macrocytosis |
6.3% |
| Myocardial Infarction |
6.3% |
| Nervous System Disorder |
6.3% |
| Oedema Peripheral |
6.3% |
| Pruritus |
6.3% |
| Septic Shock |
6.3% |
| Skin Hypopigmentation |
6.3% |
| Vomiting |
6.3% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
18.1% |
| Bipolar Disorder |
7.4% |
| Hypertension |
7.4% |
| Oesophageal Disorder |
7.4% |
| Anxiety |
6.4% |
| Depression |
6.4% |
| Dyspepsia |
6.4% |
| Panic Attack |
6.4% |
| Nervousness |
4.3% |
| Panic Disorder |
4.3% |
| Stress |
4.3% |
| Arthritis |
3.2% |
| Sleep Disorder |
3.2% |
| Agitation |
2.1% |
| Asthma |
2.1% |
| Atrial Fibrillation |
2.1% |
| Barrett's Oesophagus |
2.1% |
| Flatulence |
2.1% |
| Insomnia |
2.1% |
| Nervous System Disorder |
2.1% |
|
| Ulcer |
14.8% |
| Pharyngeal Haemorrhage |
7.4% |
| Somnolence |
7.4% |
| Toxic Epidermal Necrolysis |
7.4% |
| Visual Impairment |
7.4% |
| Weight Decreased |
7.4% |
| Abdominal Discomfort |
3.7% |
| Abdominal Pain Upper |
3.7% |
| Adverse Drug Reaction |
3.7% |
| Feeling Abnormal |
3.7% |
| Insomnia |
3.7% |
| Ischaemic Stroke |
3.7% |
| Lung Disorder |
3.7% |
| Palpitations |
3.7% |
| Priapism |
3.7% |
| Rash |
3.7% |
| Throat Irritation |
3.7% |
| Thrombosis |
3.7% |
| Vomiting |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.4% |
| Hypertension |
8.2% |
| Gastrooesophageal Reflux Disease |
8.1% |
| Osteoporosis |
6.4% |
| Depression |
5.9% |
| Pain |
4.9% |
| Crohn's Disease |
3.8% |
| Anxiety |
3.3% |
| Nausea |
2.3% |
| Fibromyalgia |
2.2% |
| Migraine |
2.2% |
| Diabetes Mellitus |
2.1% |
| Blood Cholesterol Increased |
2.0% |
| Bipolar Disorder |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Chest Pain |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Gastric Disorder |
1.5% |
| Hypothyroidism |
1.3% |
|
| Bronchiectasis |
8.8% |
| Pain |
7.0% |
| Vomiting |
7.0% |
| Dyspnoea |
6.1% |
| Nausea |
6.1% |
| Drug Ineffective |
5.3% |
| Fatigue |
5.3% |
| Palpitations |
5.3% |
| Rash |
5.3% |
| Weight Decreased |
5.3% |
| Death |
4.4% |
| Somnolence |
4.4% |
| Urinary Tract Infection |
4.4% |
| Vertigo |
4.4% |
| Abdominal Pain |
3.5% |
| Pyrexia |
3.5% |
| Swollen Tongue |
3.5% |
| Vision Blurred |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Wrong Technique In Drug Usage Process |
3.5% |
|
| Interacting |
| Prophylaxis |
28.6% |
| Coagulopathy |
14.3% |
| Gastrooesophageal Reflux Disease |
14.3% |
| Myasthenia Gravis |
14.3% |
| Nervousness |
14.3% |
| Supplementation Therapy |
14.3% |
|
|
